重组抗小鼠CD28单抗(PV-1) | Syd Labs PA007463.hs

重组抗小鼠CD28单抗(PV-1) Syd Labs PA007463.hs

重组抗小鼠CD28单抗(PV-1) | Syd Labs PA007463.hs

In stock

一键复制

Syd Labs体内实验级重组抗小鼠CD28单克隆抗体,克隆号PV-1,恒定区为亚美尼亚仓鼠IgG Kappa(Armenian hamster IgG Kappa),由哺乳动物细胞重组表达。CD28是表达于小鼠CD4+与CD8+ T细胞表面的共刺激受体,属于免疫球蛋白超家族成员,通过与抗原呈递细胞上的B7.1(CD80)/B7.2(CD86)结合,提供T细胞完全活化所必需的第二信号——在TCR信号存在时,CD28共刺激可显著增强IL-2分泌、T细胞增殖、抗凋亡(Bcl-xL上调)和效应T细胞分化,是抗感染免疫、肿瘤免疫、自身免疫病和移植排斥中的关键共刺激分子。抗CD28抗体按其识别表位可分为激动性(crosslinking后提供共刺激信号、模拟B7结合)与拮抗性(阻断B7-CD28相互作用、抑制T细胞活化)两类,PV-1克隆为亚美尼亚仓鼠抗小鼠CD28经典克隆,可用于CD28/B7通路的体内外功能分析、T细胞活化机制研究、共刺激分子与免疫检查点(如PD-1/CTLA-4)的交叉调控研究,以及T细胞亚群活化状态的流式检测。本品采用亚美尼亚仓鼠IgGκ原始同种型,经Protein G亲和纯化、SDS-PAGE纯度>95%(还原性)、LAL法内毒素<1 EU/mg、0.2 μM过滤、1× PBS配方,适合体内动物实验与各类体外功能检测。

产品参数

货号 PA007463.hs
产品名称重组抗小鼠CD28单抗(PV-1) | Syd Labs PA007463.hs
英文名 In vivo Grade Recombinant Anti-Mouse CD28 Monoclonal Antibody, Armenian Hamster IgG Kappa (Clone: PV-1)
供货商名称 Syd Labs, Inc.
品牌名 Syd Labs
别称 T 细胞特异性表面糖蛋白 CD28,TP44
克隆号 PV-1
同种型 亚美尼亚仓鼠IgG Kappa
特异性 该体内实验级重组仓鼠单克隆抗体(克隆号PV-1)特异性结合小鼠CD28
应用 ELISA、流式细胞术、中和/激动实验,以及生物分析PK、ADA等受小鼠CD28蛋白影响的生物学通路研究相关功能实验
抗体形式 0.2 μM过滤溶液,1x PBS
内毒素 根据 LAL 方法,≤1 EU每1mg 蛋白质
纯度 >95%(在还原条件下通过SDS-PAGE测定)
运输 体内实验级重组抗小鼠CD28抗体(克隆PV-1)采用冰袋运输;收到后请立即按推荐温度保存
稳定性与存储 使用手动除霜冰箱,避免反复冻融;自收货之日起12个月,按供货状态在−20 ℃至−70 ℃保存;自收货之日起1个月,按供货状态在2–8 ℃保存
注意事项
产品咨询 Syd Labs在国内只通过代理商销售其产品,不做直销。终端用户咨询价格请联系Syd Labs中国代理商。
关于Syd Labs产品如果有任何技术或其它问题,欢迎随时联系Syd Labs国内市场推广合作伙伴:武汉多找找科技有限公司,企业微信:duozhaozhao2024 联系电话:18162581039(龙经理)
应用详情 ELISA、流式细胞术、中和/激动实验,以及生物分析PK、ADA等受小鼠CD28蛋白影响的生物学通路研究相关功能实验

文献

PA007463.hs:抗小鼠CD28单克隆抗体(克隆号PV-1),体内实验级重组,亚美尼亚仓鼠IgG Kappa(In vivo Grade Recombinant Anti-Mouse CD28 Monoclonal Antibody, Armenian Hamster IgG Kappa (Clone: PV-1))

重组抗小鼠CD28单抗(PV-1)背景知识:

体内实验级重组抗小鼠CD28单克隆抗体(克隆号PV-1,小鼠IgG2a kappa)是一种针对小鼠CD28分子的激活性重组抗体。CD28主要表达于T细胞表面,是介导T细胞完整活化极其关键的共刺激受体(第二信号受体)。通过与天然配体CD80(B7-1)和CD86(B7-2)结合,CD28可协同T细胞受体(TCR,第一信号)信号通路,强效诱导T细胞克隆增殖、细胞因子(如IL-2)分泌并阻止细胞凋亡。作为经典的共刺激激动剂,抗小鼠CD28单抗(PV-1克隆)能够特异性结合小鼠CD28分子,常与抗CD3单抗配套使用,在体外T细胞扩增及体内免疫功能调控实验中发挥关键作用。

作为高品质的体内实验级重组抗小鼠CD28单克隆抗体(PV-1克隆,小鼠IgG2a kappa),该产品采用小鼠IgG2a格式并由哺乳动物细胞重组表达精制而成,具备超低内毒素、无叠氮化物及无外源载体蛋白的优势,可最大程度避免非特异性免疫干扰与体内毒性。小鼠IgG2a格式使其在同种小鼠模型中具备优异的免疫兼容性,并可配套重组小鼠IgG2a同型对照抗体进行严谨的对照分析。该抗体广泛应用于小鼠T细胞活化与分化、肿瘤免疫治疗机制、自身免疫性疾病模型以及过继性细胞免疫治疗等前沿体内外研究。

重组抗小鼠CD28单抗(PV-1)参考文献:

1. CXCL13 antibody for the treatment of autoimmune disorders
Klimatcheva, E., et al. BMC Immunol. 2015 Feb 12;16(1):6. PMID: 25879435
“The cells were incubated at 37°C for 4 days after which the cells were collected, washed and cultured in media containing 2 μg/ml of each anti-muCD3e and anti-muCD28 antibody for 3 days. For the adoptive transfer, the mice were injected i.p. with 2×10⁶ cells in 100 μl PBS. …Antibodies: …anti-murine CD3e (clone 145-2C11; BioXcell; BE0001-1); anti-murine CD28 (clone PV-1; BioXcell; BE0015-5); anti-murine IFN-γ (clone XMG1.2; BioXcell; BE0055).”

2. IL-27 and IL-12 oppose pro-inflammatory IL-23 in CD4+ T cells by inducing Blimp1
Heinemann, C., et al. Nat Commun. 2014 May 6;5:3770. PMID: 24796719
“Naive CD4+ T cells were polyclonally stimulated for 3 days with plate-bound antibody to CD3 and soluble antibody to CD28 in the absence of exogenous cytokines (Th0), or differentiated into Tr-1 cells (100 ng ml⁻¹ IL-27 plus 0.5 ng ml⁻¹ TGF-β) or Th17 cells (50 ng ml⁻¹ IL-6 plus 0.5 ng ml⁻¹ TGF-β) for microarray analysis. …For in vitro T-cell differentiation, magnetic bead-purified CD4+CD62L+ or flow cytometrically purified CD4+CD44⁻CD25⁻ T cells were stimulated for 3 days with 4 μg ml⁻¹ plate-bound antibody to CD3 (BioXcell, 145-2C11) and 2 μg ml⁻¹ soluble antibody to CD28 (BioXcell, PV-1).”

3. Ezrin and moesin are required for efficient T cell adhesion and homing to lymphoid organs
Chen, E. J. H., et al. PLoS One. 2013 Feb 28;8(2):e52368. PMID: 23468835
“T cells were stimulated in 24-well plates coated with 1 μg/mL anti-CD28 (PV1) and anti-CD3 (2C11) (both from BioXCell) for three days and maintained in DMEM supplemented with 5% FBS, penicillin, streptomycin, glutaMAX, Hepes, NEAA and β-mercaptoethanol at 37°C, 10% CO2. …To produce ezrin and/or moesin deficient murine CD4+ T cell blasts, freshly isolated ezrinflox/flox or ezrinflox/flox:CD4cre T cells were stimulated as described above and removed from stimulation for two days.”

4. IL-9 as a mediator of Th17-driven inflammatory disease
Nowak, E. C., et al. J Exp Med. 2009 Aug 3;206(8):1653-60. PMID: 19596803
“Th17 cells were generated with 2.5 ng/ml TGF-β, 20 ng/ml IL-6, 10 μg/ml αIFN-γ, and 10 μg/ml αIL-4 using 5 μg/ml of plate-bound CD3 (145-2C11; BioXCell) and CD28 (PV-1; BioXCell), respectively. …Cells were washed, counted, and restimulated in the presence of αCD3/αCD28 for 24 h before supernatants were collected for ELISA.”